查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1529577

成人疫苗市场：按疫苗、按疫苗类型、按技术、按地区

Adult Vaccines Market, By Vaccines (Influenza, Tetanus, Diphtheria, Pertussis, Varicella, Human Papillomavirus, Zoster, Measles, Mumps, Rubella, Pneumococcal, Hepatitis, Others), By Vaccine Type, By Technology, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 156 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计2024年全球成人疫苗市场规模为181亿美元，预计2031年将达318亿美元，2024年至2031年复合年增长率为8.4%。

报告范围 报告详情
基准年 2023年 2024年市场规模 181亿美元
实际资料 2019-2023 预测期 2024-2031
2024-2031 年预测期复合年增长率 8.40% 2031 年金额预测 318亿美元
图. 2024 年按地区分類的成人疫苗市占率 (%)
成人疫苗市场-IMG1

全球成人疫苗市场的成长是由政府和私人公司对成人疫苗接种计划的投资增加所推动的。成人疫苗接种越来越受欢迎，因为它们可以保护弱势群体免受严重疾病和感染疾病。人们对现有疫苗及其对成年人的好处的认识不断提高，正在鼓励更多的人接种疫苗。此外，现有成人疫苗适应症的扩大和新配方的开发正在增强对影响全世界成年人口的各种疾病的保护。然而，新兴国家高昂的开发成本和缺乏足够的疫苗接种基础设施可能会阻碍市场成长。

市场动态：

全球成人疫苗市场的成长是由成人流感、脑膜炎双球菌性脑膜炎和肺炎链球菌感染等疾病盛行率上升所推动的。根据世界卫生组织 (WHO) 统计，季节性流感每年在全球造成约 300 至 500 万重症患者，并导致 29 万至 65 万人死于呼吸道疾病。医疗保健支出的增加、政府透过疫苗接种计划提供的有利支持以及新型疫苗的推出正在推动市场成长。然而，市场开拓可能会因新兴国家认知度低、开发新疫苗相关的研发成本高以及储存需求而受到阻碍。开发不需要冷藏的耐热疫苗或成人联合疫苗可能提供市场开拓机会。

本研究的主要特点

  • 本报告对全球成人疫苗市场进行了详细分析，包括以 2023 年为基准年的预测期（2024-2031 年）的市场规模（十亿美元）和年复合成长率（CAGR%）。
  • 它还揭示了各个细分市场的潜在商机，并解释了该市场中有吸引力的投资提案的矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
  • 该报告根据公司亮点、产品系列、主要亮点、绩效和策略等参数，提供了全球成人疫苗市场主要企业的概况。
  • 该报告的见解使负责人和公司经营团队能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
  • 全球成人疫苗市场报告针对该行业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 透过用于全球成人疫苗市场分析的各种策略矩阵，将有助于相关人员做出决策。

目录

第一章 研究目的与前提

  • 研究目的
  • 先决条件
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • 一致的机会地图 (COM)

第三章市场动态、法规及趋势分析

  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会
  • 影响分析
  • 市场趋势
  • 监管场景
  • 收购和合作场景
  • 资金筹措和投资
  • PEST分析
  • 波特的分析

第四章全球成人疫苗市场 - 冠状病毒 (COVID-19) 大流行的影响

  • 整体影响
  • 政府倡议
  • COVID-19 对市场的影响

第五章 全球成人疫苗市场（依疫苗划分），2019-2031 年（十亿美元）

  • 介绍
  • 流感
  • 破伤风、白喉、百日咳 (Td/Tdap)
  • 水痘
  • 人类乳突病毒
  • 带状疱疹
  • 麻疹、德国麻疹、腮腺炎 (MMR)
  • 肺炎球菌
  • 肝炎
  • 其他的

第六章 全球成人疫苗市场，依疫苗类型，2019-2031 年（十亿美元）

  • 介绍
  • 单价
  • 多效价的

第七章 全球成人疫苗市场，依技术划分，2019-2031 年（十亿美元）

  • 介绍
  • 减毒活疫苗
  • 灭活病毒/细菌疫苗
  • 类毒素疫苗
  • 重组疫苗
  • 结合疫苗

第八章2019-2031 年全球成人疫苗市场（按地区）（十亿美元）

  • 介绍
  • 拉丁美洲
  • 欧洲
  • 亚太地区
  • 中东

第9章 竞争格局

  • 公司简介
    • GlaxoSmithKline plc
    • Merck &Co., Inc.
    • Pfizer Inc.
    • Sanofi Pasteur
    • AstraZeneca
    • Johnson &Johnson
    • Novavax, Inc.
    • Moderna, Inc.
    • Inovio Pharmaceuticals, Inc.
    • Bavarian Nordic
    • Dynavax Technologies Corporation
    • BioNTech S
    • Emergent BioSolutions Inc.
    • Serum Institute of India Pvt. Ltd.
    • Bharat Biotech
    • Sinovac Biotech Ltd.

第10章分析师建议

  • 上升和下降
  • 综合机会图

第十一章 参考文献与调查方法

  • 参考
  • 调查方法
简介目录
Product Code: CMI1091

Global adult vaccines market is estimated to be valued at USD 18.10 Bn in 2024 and is expected to reach USD 31.80 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 8.4% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: US$ 18.10 Bn
Historical Data for: 2019 to 2023 Forecast Period: 2024 to 2031
Forecast Period 2024 to 2031 CAGR: 8.40% 2031 Value Projection: US$ 31.80 Bn
Figure. Adult Vaccines Market Share (%), By Region 2024
Adult Vaccines Market - IMG1

Global adult vaccines market growth is driven by increasing investments by governments and private firms in adult vaccination programs. Adult vaccinations have gained popularity as these protect vulnerable groups from serious diseases and infections. Growing awareness about available vaccines and their benefits for adults has prompted more individuals to get vaccinated. Moreover, expansion of indications for existing adult vaccines and development of new formulations have strengthened prevention against various diseases affecting the adult population worldwide. However, high development costs and lack of adequate vaccination infrastructure in developing nations can hamper the market growth.

Market Dynamics:

Global adult vaccines market growth is driven by rising prevalence of diseases such as influenza, meningococcal meningitis, pneumococcal infection, and others among adults. According to the World Health Organization, seasonal influenza results in severe illness in around 3-5 million cases and 290,000-650,000 respiratory deaths globally every year. Increasing healthcare expenditures, favorable government support through vaccination programs and introduction of novel vaccines can drive the market growth. However, low awareness in developing countries, high R&D costs associated with development of new vaccines and storage requirements can hamper the market growth. Development of thermostable vaccines without refrigeration needs and combined adult vaccine formulations can offer opportunities for market players.

Key Features of the Study:

  • This report provides in-depth analysis of the global adult vaccines market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global adult vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include GlaxoSmithKline, Sanofi Pasteur, Merck, Novavax, Pfizer, and CSL Limited
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global adult vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global adult vaccines market

Detailed Segmentation-

  • By Vaccines
    • Influenza
    • Tetanus, Diphtheria, Pertussis (Td/Tdap)
    • Varicella
    • Human Papillomavirus
    • Zoster
    • Measles, Mumps, Rubella (MMR)
    • Pneumococcal
    • Hepatitis
    • Others
  • By Vaccine Type
    • Monovalent
    • Multivalent
  • By Technology
    • Live Attenuated Vaccines
    • Inactivated Viral/Bacterial Vaccines
    • Toxoid Vaccines
    • Recombinant Vaccines
    • Conjugate Vaccines
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • GlaxoSmithKline plc
    • Merck & Co., Inc.
    • Pfizer Inc.
    • Sanofi Pasteur
    • AstraZeneca
    • Johnson & Johnson
    • Novavax, Inc.
    • Moderna, Inc.
    • Inovio Pharmaceuticals, Inc.
    • Bavarian Nordic
    • Dynavax Technologies Corporation
    • BioNTech S
    • Emergent BioSolutions Inc.
    • Serum Institute of India Pvt. Ltd.
    • Bharat Biotech
    • Sinovac Biotech Ltd.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Vaccines
    • Market Snapshot, By Vaccine Type
    • Market Snapshot, By Technology
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Adult Vaccines Market - Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Adult Vaccines Market, By Vaccines, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Influenza
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Tetanus, Diphtheria, Pertussis (Td/Tdap)
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Varicella
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Human Papillomavirus
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Zoster
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Measles, Mumps, Rubella (MMR)
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Pneumococcal
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Hepatitis
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Adult Vaccines Market, By Vaccine Type, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Monovalent
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Multivalent
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Adult Vaccines Market, By Technology, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Live Attenuated Vaccines
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Inactivated Viral/Bacterial Vaccines
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Toxoid Vaccines
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Recombinant Vaccines
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Conjugate Vaccines
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Adult Vaccines Market, By Region, 2019 - 2031, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2020-2031
    • Regional Trends
      • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccines, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccines, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccines, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccines, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccines, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
      • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccines, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Company Profiles
    • GlaxoSmithKline plc
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Merck & Co., Inc.
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Pfizer Inc.
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Sanofi Pasteur
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • AstraZeneca
    • Johnson & Johnson
    • Novavax, Inc.
    • Moderna, Inc.
    • Inovio Pharmaceuticals, Inc.
    • Bavarian Nordic
    • Dynavax Technologies Corporation
    • BioNTech S
    • Emergent BioSolutions Inc.
    • Serum Institute of India Pvt. Ltd.
    • Bharat Biotech
    • Sinovac Biotech Ltd.

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact